Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11207)
All Articles published online
|
Publishing Process of This Article
|
Apr 26, 2017 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Meta-Analysis
ISSN
2308-3840
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Undela K, Shah CS, Mothe RK. Statin use and risk of cancer: An overview of meta-analyses. World J Meta-Anal 2017; 5(2): 41-53 [DOI: 10.13105/wjma.v5.i2.41] |
|---|---|
| URL: | https://www.wjgnet.com/2308-3840/full/v5/i2/41.htm |
| Number | Citing Articles |
| 1 |
Katarzyna Regulska, Miłosz Regulski, Bartosz Karolak, Marcin Michalak, Marek Murias, Beata Stanisz. Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs. Pharmacological Research 2019; 147: 104326 doi: 10.1016/j.phrs.2019.104326
|
| 2 |
Liang Gu, Sourav Taru Saha, Jodie Thomas, Mandeep Kaur. Targeting cellular cholesterol for anticancer therapy. The FEBS Journal 2019; 286(21): 4192 doi: 10.1111/febs.15018
|
| 3 |
Katarzyna Regulska, Miłosz Regulski, Bartosz Karolak, Marek Murias, Beata Stanisz. Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing. Drug Discovery Today 2019; 24(4): 1059 doi: 10.1016/j.drudis.2019.03.010
|
| 4 |
Md. Mohaimenul Islam, Tahmina Nasrin Poly, Bruno Andreas Walther, Hsuan-Chia Yang, Yu-Chuan (Jack) Li. Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies. Cancers 2020; 12(3): 671 doi: 10.3390/cancers12030671
|
| 5 |
I. I. Shaposhnik, V. V. Genkel. Antitumor effects of cardiovascular drugs. Meditsinskiy sovet = Medical Council 2020; (14): 56 doi: 10.21518/2079-701X-2020-14-56-62
|
| 6 |
Stephanie Bridgeman, Wendy Northrop, Gaewyn Ellison, Thiru Sabapathy, Phillip Melton, Philip Newsholme, Cyril Mamotte. Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes. Cancers 2019; 11(4): 516 doi: 10.3390/cancers11040516
|
| 7 |
Romina Armando, Diego Mengual G�mez, Daniel Gomez. New drugs are not enough‑drug repositioning in oncology: An update. International Journal of Oncology 2020; doi: 10.3892/ijo.2020.4966
|
| 8 |
Jisha Pillai U, Anindita Ray, Meenu Maan, Mainak Dutta. Repurposing drugs targeting metabolic diseases for cancer therapeutics. Drug Discovery Today 2023; 28(9): 103684 doi: 10.1016/j.drudis.2023.103684
|
| 9 |
Mohammed Batais, Turky Almigbal, Khalid Alotaibi, Abdulaziz Alodhayani, Abdullah Alkhushail, Abdulrahman Altheaby, Mashhor Alhantoushi, Saad Alsaad, Sultan Al Dalbhi, Yasser Alghamdi. Angiotensin converting enzyme inhibitors and risk of lung cancer. Medicine 2021; 100(17): e25714 doi: 10.1097/MD.0000000000025714
|
| 10 |
Veronika Piskovatska, Olha Strilbytska, Alexander Koliada, Alexander Vaiserman, Oleh Lushchak. Biochemistry and Cell Biology of Ageing: Part II Clinical Science. Subcellular Biochemistry 2019; 91: 339 doi: 10.1007/978-981-13-3681-2_13
|
| 11 |
Analia Veitz-Keenan, Thamar Delia Silvestre Calle, Marco Bergamini. Limited Evidence Suggests Metformin Might Be Beneficial to Reduce Head and Neck Cancer Risk and Increase Overall Survival, While Any Benefit With Antiinflammatory Drugs Is Inconsistent. Journal of Evidence Based Dental Practice 2019; 19(3): 298 doi: 10.1016/j.jebdp.2019.101340
|